Ceragon earnings missed by $0.04, revenue fell short of estimates By Investing.com
![Ceragon earnings missed by $0.04, revenue fell short of estimates](https://nlbulletin.com/wp-content/uploads/2023/02/Ceragon-earnings-missed-by-004-revenue-fell-short-of-estimates-780x470.jpg)
[ad_1]
Investing.com – Ceragon (NASDAQ: CRNT) reported fourth quarter EPS of $0.000, $0.04 worse than the analyst estimate of $0.040. Revenue for the quarter came in at $75.5M versus the consensus estimate of $82.13M.
Guidance
Ceragon sees FY 2023 revenue of $325.000M-$345.000M versus the analyst consensus of $330.000M.
Ceragon’s stock price closed at $2.180. It is up 17.200% in the last 3 months and down -3.410% in the last 12 months.
Ceragon saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Ceragon’s stock price’s past reactions to earnings here.
According to InvestingPro, Ceragon’s Financial Health score is “fair performance“.
Check out Ceragon’s , and Ceragon’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
[ad_2]
Source link